Navigation Links
Parkinson's disease patients following subthalamic nucleus deep brain stimulation: fully understanding of social maladjustment
Date:12/4/2013

Subthalamic nucleus deep brain stimulation can significantly improve the motor features of the Parkinson's disease in carefully selected patients. However, effects of subthalamic nucleus deep brain stimulation on the social adjustment, coping strategies and mental health-related quality of life of these patients remain unclear. In addition, an important concern has been that most studies have reported no improvement in social adaptation after subthalamic nucleus deep brain stimulation in some Parkinson's disease patients. Meyer Mylne and coworkers from Lorraine University, France review the literatures regarding effects of bilateral subthalamic nucleus deep brain stimulation on social adjustment, quality of life and coping strategies in patients with Parkinson's disease. Surprisingly, some specific dimensions of quality of life, "psychological" aspects and social adjustment do not always improve, and they could sometimes be even worse. The preoperative expectations of Parkinson's disease patients who received subthalamic nucleus deep brain stimulation should be carefully considered because postoperative social maladjustment is often observed in a few patients. Therefore, effective strategies are searched to avoid the disappointments from these patients and their relatives and improve patients' quality of life. The relevant article is published in the Neural Regeneration Research (Vol. 8, No. 30, 2013).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert

Page: 1

Related medicine news :

1. Parkinsons drug helps older people to make decisions
2. Witnessing, Experiencing Traumatic Events May Worsen Heart Disease
3. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
4. Mayo Clinic offers newly approved treatment for acid reflux disease
5. Spouses of Cancer Patients May Have Raised Risk of Heart Disease, Stroke
6. Huntingtons Disease Linked to Reduced Cancer Risk in Study
7. AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases
8. Role of Screening, Monitoring in Early Kidney Disease Unclear
9. No Proof That Gum Disease Causes Heart Disease, Experts Say
10. 19th century therapy for Parkinsons disease may help patients today
11. Cellular pathway linked to diabetes, heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: